FindTrial
Sign In

The incidence of cancer according to calcium channel blocker: a nationwide cohort study

The incidence of cancer according to calcium channel blocker: a nationwide cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006401
Enrollment
100000
Registered
2021-07-29
Start date
2022-01-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Wonju College of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: By using the national health database system we extract the patients who performed health check-up at least twice between 2009 and 2012

Exclusion criteria

Exclusion criteria: age blow 19 years or above 90 years

Design outcomes

Primary

MeasureTime frame
Cancer incidence—

Secondary

MeasureTime frame
mortality—

Countries

Korea, Republic of

Contacts

Public ContactJun Young Lee

Yonsei University Wonju College of Medicine

junyoung07@yonsei.ac.kr+82-33-741-0935

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026